Simultaneous inference of treatment effect modification by intermediate response endpoint principal strata with application to vaccine trials
From MaRDI portal
Publication:6636037
DOI10.1515/IJB-2018-0058MaRDI QIDQ6636037FDOQ6636037
Authors: Yingying Zhuang, Ying Huang, Peter B. Gilbert
Publication date: 12 November 2024
Published in: The International Journal of Biostatistics (Search for Journal in Brave)
Cites Work
- A resampling method based on pivotal estimating functions
- Principal stratification in causal inference
- Measurement Error in Nonlinear Models
- A Pseudoscore Estimator for Regression Problems With Two-Phase Sampling
- Comparing biomarkers as principal surrogate endpoints
- Evaluating Candidate Principal Surrogate Endpoints
- Related Causal Frameworks for Surrogate Outcomes
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- Design and estimation for evaluating principal surrogate markers in vaccine trials
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
Cited In (1)
This page was built for publication: Simultaneous inference of treatment effect modification by intermediate response endpoint principal strata with application to vaccine trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6636037)